Immunological Responses to mRNA Vaccines
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 30 April 2026 | Viewed by 13
Special Issue Editor
Special Issue Information
Dear Colleagues,
Vaccines provide immunity to individuals by inducing immunogenicity through vaccination. They reduce the risk of disease at the individual level and decrease the likelihood of epidemic outbreaks at the population level. Research on vaccine immunogenicity is vital for determining vaccination strategies, including the number of doses, dosing intervals, and target populations.
This Special Issue aims at exploring how host immunity is induced, enhanced, and maintained against microorganisms through vaccination. As vaccine development becomes increasingly advanced, immunity against many infectious diseases is now achieved primarily through vaccine-induced immunity rather than natural infection. As a result, studies on the duration of vaccine-induced immunogenicity are becoming more important. Additionally, quantifying immunogenicity helps differentiate between populations with low and high immune responses. Given the rising number of immunocompromised individuals, research targeting special populations is urgently needed.
We welcome original research articles and reviews for this Special Issue. Relevant topics may include immunogenicity assessments using various methodologies, as well as large-scale studies evaluating immune responses following vaccination
We look forward to receiving your contributions.
Dr. Hyeri Seok
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infectious
- vaccine
- immune response
- immunogenicity
- vaccine-induced immunity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
